Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Nature Communications|September 30, 2025
Parallel within-host evolution alters virulence factors in an opportunistic Klebsiella pneumoniae during a hospital outbreakGreta Zaborskytė, Karin Hjort, Birgitta Lytsy, et al.
Nature Communications|April 10, 2026
Rapid evolution of Klebsiella pneumoniae biofilms in vitro delineates adaptive changes selected during infectionGreta Zaborskytė, Patrícia Coelho, Marie Wrande, et al.
The Journal of Antimicrobial Chemotherapy|February 13, 2016
Combinations of mutations in envZ, ftsI, mrdA, acrB and acrR can cause high-level carbapenem resistance in Escherichia coliMarlen Adler, Mehreen Anjum, Dan I Andersson, et al.
The Journal of Antimicrobial Chemotherapy|September 15, 2012
Influence of acquired β-lactamases on the evolution of spontaneous carbapenem resistance in Escherichia coliMarlen Adler, Mehreen Anjum, Dan I Andersson, et al.
Antimicrobial Agents and Chemotherapy|June 2, 2022
Evolutionary Trajectories toward High-Level β-Lactam/β-Lactamase Inhibitor Resistance in the Presence of Multiple β-LactamasesFredrika Rajer, Lisa Allander, Philip A Karlsson, et al.
The Journal of Antimicrobial Chemotherapy|June 23, 2016
A pharmacokinetic-pharmacodynamic model characterizing the emergence of resistant Escherichia coli subpopulations during ertapenem exposureWanchana Ungphakorn, Thomas Tängdén, Linus Sandegren, et al.
Scientific Reports|July 18, 2019
Genome and plasmid diversity of Extended-Spectrum β-Lactamase-producing Escherichia coli ST131 - tracking phylogenetic trajectories with Bayesian inferenceSofia Ny, Linus Sandegren, Marco Salemi, et al.
The Journal of Antimicrobial Chemotherapy|June 12, 2008
Nitrofurantoin resistance mechanism and fitness cost in Escherichia coliLinus Sandegren, Anton Lindqvist, Gunnar Kahlmeter, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|May 3, 2014
The gull (Chroicocephalus brunnicephalus) as an environmental bioindicator and reservoir for antibiotic resistance on the coastlines of the Bay of BengalBadrul Hasan, Åsa Melhus, Linus Sandegren, et al.
The Journal of Antimicrobial Chemotherapy|March 13, 2013
Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic modelThomas Tängdén, Marlen Adler, Otto Cars, et al.
Pageof 6